標(biāo)題: Titlebook: Statistics and Simulation; IWS 8, Vienna, Austr Jürgen Pilz,Dieter Rasch,Karl Moder Conference proceedings 2018 Springer International Publ [打印本頁(yè)] 作者: estrange 時(shí)間: 2025-3-21 19:29
書(shū)目名稱(chēng)Statistics and Simulation影響因子(影響力)
書(shū)目名稱(chēng)Statistics and Simulation影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Statistics and Simulation網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Statistics and Simulation網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Statistics and Simulation被引頻次
書(shū)目名稱(chēng)Statistics and Simulation被引頻次學(xué)科排名
書(shū)目名稱(chēng)Statistics and Simulation年度引用
書(shū)目名稱(chēng)Statistics and Simulation年度引用學(xué)科排名
書(shū)目名稱(chēng)Statistics and Simulation讀者反饋
書(shū)目名稱(chēng)Statistics and Simulation讀者反饋學(xué)科排名
作者: 啪心兒跳動(dòng) 時(shí)間: 2025-3-21 23:16
study the complex genetic basis of inter-patient variability in response to drug therapy.? Based upon the success of its first edition, the second edition of .Pharmacogenomics: Methods And Protocols. aims to continue providing readers with high-quality content on the most innovative and commonly ad作者: 思鄉(xiāng)病 時(shí)間: 2025-3-22 02:38 作者: Legend 時(shí)間: 2025-3-22 06:27
Golbon Zakeri,Geoff Pritchardy implementation advice to ensure successful results.Understanding an individual‘s genetic makeup is the key to creating personalized drugs with greater efficacy and safety, and pharmacogenomics aims to study the complex genetic basis of inter-patient variability in response to drug therapy.? Based 作者: 經(jīng)典 時(shí)間: 2025-3-22 10:31
Clemens Draxler,Klaus D. Kubingery implementation advice to ensure successful results.Understanding an individual‘s genetic makeup is the key to creating personalized drugs with greater efficacy and safety, and pharmacogenomics aims to study the complex genetic basis of inter-patient variability in response to drug therapy.? Based 作者: Root494 時(shí)間: 2025-3-22 13:40
Zuzana Prá?kováy implementation advice to ensure successful results.Understanding an individual‘s genetic makeup is the key to creating personalized drugs with greater efficacy and safety, and pharmacogenomics aims to study the complex genetic basis of inter-patient variability in response to drug therapy.? Based 作者: 機(jī)密 時(shí)間: 2025-3-22 20:23
y implementation advice to ensure successful results.Understanding an individual‘s genetic makeup is the key to creating personalized drugs with greater efficacy and safety, and pharmacogenomics aims to study the complex genetic basis of inter-patient variability in response to drug therapy.? Based 作者: 滑動(dòng) 時(shí)間: 2025-3-22 22:45 作者: SNEER 時(shí)間: 2025-3-23 04:47 作者: interference 時(shí)間: 2025-3-23 08:25 作者: 磨碎 時(shí)間: 2025-3-23 10:53 作者: FLING 時(shí)間: 2025-3-23 17:25
y implementation advice to ensure successful results.Understanding an individual‘s genetic makeup is the key to creating personalized drugs with greater efficacy and safety, and pharmacogenomics aims to study the complex genetic basis of inter-patient variability in response to drug therapy.? Based 作者: 淺灘 時(shí)間: 2025-3-23 20:28 作者: 傳授知識(shí) 時(shí)間: 2025-3-23 22:11 作者: Fallibility 時(shí)間: 2025-3-24 05:39 作者: milligram 時(shí)間: 2025-3-24 07:44
Ekaterina Bulinskaya,Julia Gusakwing apprec- tion for the challenges in translating this new information into clinical utility, including scientific, commercial, ethical, and policy challenges. Pharmacogenomics and Personalized Medicine, which is part of the Methods in Pharmacology and Toxicology series, comprises chapters on sele作者: 過(guò)于平凡 時(shí)間: 2025-3-24 12:59
Christian Quast,Lubo? St?elec,Rastislav Potocky,Jozef Kiseǐák,Milan Stehlíkformed consent form, and applications in adverse drug reacticoncerns within the pharmaceutical industry about generating data that might be difficult to interpret in a regulated environment. There is also a growing apprec- tion for the challenges in translating this new information into clinical uti作者: 易怒 時(shí)間: 2025-3-24 14:51
Alexander Andronov,Tatjana Jurkinaformed consent form, and applications in adverse drug reacticoncerns within the pharmaceutical industry about generating data that might be difficult to interpret in a regulated environment. There is also a growing apprec- tion for the challenges in translating this new information into clinical uti作者: 奴才 時(shí)間: 2025-3-24 22:35
formed consent form, and applications in adverse drug reacticoncerns within the pharmaceutical industry about generating data that might be difficult to interpret in a regulated environment. There is also a growing apprec- tion for the challenges in translating this new information into clinical uti作者: intention 時(shí)間: 2025-3-25 00:23 作者: Nmda-Receptor 時(shí)間: 2025-3-25 06:38 作者: 愚笨 時(shí)間: 2025-3-25 10:52
hapters include introductions to the respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Comprehensive and thoroughly updated, .Pharmacogenomics: Methods And Protocol作者: packet 時(shí)間: 2025-3-25 15:42 作者: 和平 時(shí)間: 2025-3-25 16:18 作者: 加劇 時(shí)間: 2025-3-25 22:20 作者: Middle-Ear 時(shí)間: 2025-3-26 04:12 作者: 漂浮 時(shí)間: 2025-3-26 04:40 作者: 極為憤怒 時(shí)間: 2025-3-26 09:53 作者: CHASM 時(shí)間: 2025-3-26 16:23 作者: 詞匯記憶方法 時(shí)間: 2025-3-26 19:45 作者: ADJ 時(shí)間: 2025-3-26 23:56 作者: 額外的事 時(shí)間: 2025-3-27 02:08 作者: 悠然 時(shí)間: 2025-3-27 09:07
Harish S. Bhat,R. W. M. A. Madushani,Shagun Rawatnts, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..?.Comprehensive and thoroughly updated, .Pharmacogenomics: Methods And Protocol978-1-4939-5935-8978-1-62703-435-7Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: 使困惑 時(shí)間: 2025-3-27 10:24 作者: Acetaminophen 時(shí)間: 2025-3-27 16:15 作者: 魔鬼在游行 時(shí)間: 2025-3-27 19:12 作者: HUMP 時(shí)間: 2025-3-28 00:27
Christian Quast,Lubo? St?elec,Rastislav Potocky,Jozef Kiseǐák,Milan Stehlíkracticalities, and obstacles in applying pharmac- enomics. Generally, the book avoids statements such as “Pharmacogenomics is going to revolutionize the practice of medicine,” which are neither realistic nor pa978-1-61737-921-5978-1-59745-439-1Series ISSN 1557-2153 Series E-ISSN 1940-6053 作者: 干旱 時(shí)間: 2025-3-28 02:51
Alexander Andronov,Tatjana Jurkinaracticalities, and obstacles in applying pharmac- enomics. Generally, the book avoids statements such as “Pharmacogenomics is going to revolutionize the practice of medicine,” which are neither realistic nor pa978-1-61737-921-5978-1-59745-439-1Series ISSN 1557-2153 Series E-ISSN 1940-6053 作者: 過(guò)時(shí) 時(shí)間: 2025-3-28 07:31 作者: GUEER 時(shí)間: 2025-3-28 11:38 作者: Chronic 時(shí)間: 2025-3-28 16:54
Power and Sample Size Considerations in Psychometricsic models are given. Theoretical as well as computational issues and simulation techniques, respectively, are considered. The treatment of the topic includes maximum likelihood and least squares procedures applied in the framework of generalized linear (mixed) models. Numerical examples and comparisons of the procedures to be introduced are quoted.作者: dry-eye 時(shí)間: 2025-3-28 19:18 作者: 說(shuō)明 時(shí)間: 2025-3-29 01:07 作者: SLAG 時(shí)間: 2025-3-29 03:12 作者: Incommensurate 時(shí)間: 2025-3-29 08:56 作者: defile 時(shí)間: 2025-3-29 12:05
Springer Proceedings in Mathematics & Statisticshttp://image.papertrans.cn/s/image/876716.jpg作者: 發(fā)怨言 時(shí)間: 2025-3-29 19:19
https://doi.org/10.1007/978-3-319-76035-3mathematical statistics; statistical simulation; experimental design; stochastic simulation; Monte Carlo作者: ostrish 時(shí)間: 2025-3-29 20:15 作者: Salivary-Gland 時(shí)間: 2025-3-30 03:30 作者: lymphedema 時(shí)間: 2025-3-30 04:41
Statistics and Simulation978-3-319-76035-3Series ISSN 2194-1009 Series E-ISSN 2194-1017 作者: 銀版照相 時(shí)間: 2025-3-30 08:47 作者: facilitate 時(shí)間: 2025-3-30 12:21
Design and Analysis of Simulation Experimentstor) types, namely first-order or second-order polynomial regression, and Kriging (or Gaussian process). The metamodel type determines the design of the simulation experiment, which determines the input combinations of the simulation model. Before applying these metamodels, the analysts should scree作者: AND 時(shí)間: 2025-3-30 18:15
A Review of Simulation Usage in the New Zealand Electricity Marketet (NZEM). We start by describing the operation of the NZEM with a particular focus on how electricity prices are calculated for each time period. The complexity of this mechanism, in conjunction with uncertainty surrounding factors such as consumption levels, motivates the use of simulation. We wil作者: entail 時(shí)間: 2025-3-30 21:06
